We are live on ! Find out more
CNSY

Cerenome, Inc. Common Stock

9 hedge funds and large institutions have $780K invested in Cerenome, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 99 (0)

0% more ownership

Funds ownership: 0.46%0.46% (+0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

20% less capital invested

Capital invested by funds: $981K → $780K (-$201K)

Holders
9
Holders Change
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CNSY Hedge Fund Activity: Q4 2024 in Review

9 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Cerenome, Inc. Common Stock (CNSY) for Q4 2024, worth a combined $780K — down 20% from $981K a quarter earlier.

Fund positioning in CNSY was balanced in Q4 2024: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $18.7K. The largest seller was Ashton Thomas Private Wealth, exiting entirely with an estimated $18.9K sold.

  • 9 institutional investors held Cerenome, Inc. Common Stock (CNSY) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $780K of Cerenome, Inc. Common Stock stock for Q4 2024, down 20% quarter-over-quarter.
  • 2 funds opened new Cerenome, Inc. Common Stock positions in Q4 2024 and 2 closed out, a net change of 0 holders.
  • The largest Cerenome, Inc. Common Stock buyer in Q4 2024 was Two Sigma Securities, an estimated $18.7K added.
  • The largest Cerenome, Inc. Common Stock seller in Q4 2024 was Ashton Thomas Private Wealth, an estimated $18.9K sold.

Based on aggregated 13F filings for Q4 2024.